Bruce Luehrs
Founder , Managing Partner @ Rittenhouse Ventures
Greater Philadelphia Area, United States
Bruce Luehrs is a Series A investor at Rittenhouse Ventures in Greater Philadelphia Area focused on Software and Health Care. Bruce Luehrs - Partner @ Rittenhouse Ventures
- Total investments:
- 19
- Last investment:
- Lead investor:
- 63%
Last updated:
For AI agents: llms.txt
Industries Bruce Luehrs invests in
Stages Bruce Luehrs invests in
Countries Bruce Luehrs invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Software 4 (21%)
- Health Care 4 (21%)
- Enterprise Software 3 (16%)
- Analytics 2 (11%)
- Biotechnology 2 (11%)
Stage
- Series A 5 (26%)
- Series B 2 (11%)
- Series C 2 (11%)
- Funding Round 1 (5%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
AI-powered clinical imaging intelligence for drug development. We make imaging a strategic asset: faster trials, stronger evidence, more confident decisions. | $11M / Series C / Mar 12, 2020 | |
|
|
AI-powered clinical imaging intelligence for drug development. We make imaging a strategic asset: faster trials, stronger evidence, more confident decisions. | $5.1M / Series B / Dec 20, 2016 | |
|
|
AI-powered clinical imaging intelligence for drug development. We make imaging a strategic asset: faster trials, stronger evidence, more confident decisions. | $5.1M / Series B / Dec 20, 2016 | |
|
|
DecisionSim is a simulation-based learning platform that enhances decision-making by allowing organizations to easily create assessment, education, and training programs that deliver insights and improve outcomes through “real-world” engagement. | $1.9M / Series A / Sep 02, 2015 | |
|
|
DecisionSim is a simulation-based learning platform that enhances decision-making by allowing organizations to easily create assessment, education, and training programs that deliver insights and improve outcomes through “real-world” engagement. | $1.9M / Series A / Sep 02, 2015 | |
|
|
Noble Biomaterials is a global leader in antimicrobial and conductivity solutions for soft surface applications. They supply medical components to the US military, and a US EPA–registered antimicrobial manufacturer. | Series C / Jul 01, 2013 | |
|
|
Noble Biomaterials is a global leader in antimicrobial and conductivity solutions for soft surface applications. They supply medical components to the US military, and a US EPA–registered antimicrobial manufacturer. | Series C / Jul 01, 2013 | |
|
|
vcopious is your in virtual environments for Training, Conferences, Trade Shows, Webinars, Seminars, Career Fairs, and Briefings. vcopious is a virtual environment software platform that enables companies to connect with their global communities to build brands, increase lead generation and engage target audiences. By capturing relevant usermetrics in real time, vcopious enables companies to gain actionable insights for applications ranging from product launches, customer service portals and hybrid conferences, to employee training and virtual events. vcopious software can be deployed in a licensed, hosted or SAAS environment. The vcopious software platform enables enterprises to seamlessly connect relevant internal assets, including E-commerce, CRM, social media, customer records, learning systems and contact centers, while collecting every user activity within the platform. vcopious is a leading cost-reduction and revenue enhancement strategy for multinational organizations across industry categories. | Oct 10, 2011 | |
|
|
vcopious is your in virtual environments for Training, Conferences, Trade Shows, Webinars, Seminars, Career Fairs, and Briefings. vcopious is a virtual environment software platform that enables companies to connect with their global communities to build brands, increase lead generation and engage target audiences. By capturing relevant usermetrics in real time, vcopious enables companies to gain actionable insights for applications ranging from product launches, customer service portals and hybrid conferences, to employee training and virtual events. vcopious software can be deployed in a licensed, hosted or SAAS environment. The vcopious software platform enables enterprises to seamlessly connect relevant internal assets, including E-commerce, CRM, social media, customer records, learning systems and contact centers, while collecting every user activity within the platform. vcopious is a leading cost-reduction and revenue enhancement strategy for multinational organizations across industry categories. | Oct 10, 2011 | |
|
|
Miria Systems, Inc., is a provider of Digital Business Automation Solutions in the cloud. Miria offers advanced technology solutions built on the IBM DBA Platform, for capture & OCR, AP Automation, Payment Automation & Optimization, and automation of other financial processes. Miria offers additional applications to completely configure thefull ActiveOps solution to each unique business. As a subsidiary of OSG Billing, and an IBM Gold Business Partner, Miria enables the digital transformation of business processes through the highest standards of advanced digital business automation technologies. | Series A / Apr 29, 2011 | |
| See all 19 investments → | |||
Co-Investors
About Rittenhouse Ventures
Rittenhouse Ventures is a Philadelphia-based early-stage venture fund that invests in capital-efficient emerging technology companies across Pennsylvania and the Mid-Atlantic region. Rittenhouse invests in small (generally $1 to $3 million) financing rounds of early-stage information technology companies that utilize emerging technologies to createcompelling business opportunities. While the Fund invests across the information technology spectrum, it has a primary vertical focus on Healthcare Information Technology and Pharmaceutical IT. It also invests in Technology-Enabled Services companies focused on other verticals including Financial Services Information Technology and Outsourced Business Services.
Rittenhouse Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Bruce Luehrs
Founder , Managing Partner
|
|||
|
Jayson Tischler
Principal
|
|||
|
Saul Richter
Founder & Managing Partner
|
|||
|
Britton H. Murdoch
Fund Principal
|
|||
|
Justin Hanley
Associate
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Bruce Luehrs invest in?
Bruce Luehrs invests primarily in Software, Health Care and Enterprise Software startups, most often at Series A and Series B stage. Most of the 19 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Bruce Luehrs?
Public channels for Bruce Luehrs include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Bruce Luehrs last invest?
The most recent investment recorded for Bruce Luehrs closed in Mar 2020. Shizune tracks 19 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!